Arca
Skip to content
Tools
Tools

Inflammatory bowel disease

Drug research and approvals for inflammatory bowel disease: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 560 studies of inflammatory bowel disease are recruiting on ClinicalTrials.gov, and Health Canada has authorized 4 drug trials for it since 2013.

  • Recruiting worldwide: 560
  • Trials authorized in Canada: 4
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 560 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 10

Phase 2 12 of 16

Phase 1 or earlier 12 of 20

How its trials ended

1,215 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 191 whose ending is known, 37% met their primary endpoint, 4% missed it and 60% stopped early.

  • Completed, result not reported45237%
  • Ongoing32927%
  • Status unknown24320%
  • Met its primary endpoint706%
  • Stopped: other or unclear645%
  • Stopped: enrollment or feasibility353%
  • Missed its primary endpoint71%
  • Stopped: sponsor or business decision6<1%
  • Stopped: funding4<1%
  • Stopped: lack of efficacy3<1%
  • Stopped: safety2<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
Mar 13, 2026A study to evaluate the long-term safety and efficacy of long-acting antibodies as single agents and in combinations in participants with inflammatory bowel…SPY001-001 / SPY002-091 / SPY003-207Spyre TherapeuticsOngoing
Aug 1, 2023Efficacy and safety of budesonide mmx® and budesonide cr for induction of remission in microscopic colitis: a prospective, randomized, active comparator pilot…BudesonideGovernors of The University of CalgaryPending
Mar 9, 2018Naturalistic monitoring of microglial activation in inflammatory bowel disease18F feppa / [11C]-SL25.1188Pet Centre Centre for Addiction and Mental HealthOngoing
Oct 1, 2015A phase 4, multicenter, open-label study of serum infliximab concentrations and efficacy and safety of dose escalation in pediatric patients with inflammatory…RemicadeJohnson & JohnsonClosed

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.